Filtered By:
Condition: Diabetes
Therapy: Dialysis
This page shows you your search results in order of relevance. This is page number 17.
Order by Relevance | Date
Total 274 results found since Jan 2013.
SGLT2 Inhibitors: The Next Blockbuster Multifaceted Drug?
Medicina (Kaunas). 2023 Feb 16;59(2):388. doi: 10.3390/medicina59020388.ABSTRACTSodium glucose cotransporter 2 inhibitor (SGLT2i) is a class of drugs that were originally intended for decreasing blood glucose in diabetes. However, recent trials have shown that there are other beneficial effects. Major clinical trials involving SGLT2i medications from 2015 to 2022 were reviewed using PUBMED search. Recent major SGLT2i landmark trials have demonstrated benefits for cardiovascular disease (reduce major adverse cardiovascular events (heart attack, stroke, cardiovascular death), hospitalization for heart failure, all-cause deat...
Source: Medicina (Kaunas) - February 25, 2023 Category: Universities & Medical Training Authors: Jonathan C H Chan Michael C Y Chan Source Type: research
Prosthesis Choice in Dialysis Patients Undergoing Mitral Valve Replacement
CONCLUSIONS: MVR in dialysis patients carries significant morbidity and increased mid-term mortality. Decreased life-expectancy should be considered in the tailoring of prosthesis choice to dialysis-dependent patients.PMID:37245789 | DOI:10.1016/j.athoracsur.2023.05.015
Source: The Annals of Thoracic Surgery - May 28, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Amit Iyengar Cindy Song Noah Weingarten David Rekhtman David A Herbst Max Shin Mark R Helmers Pavan Atluri Source Type: research
